"Breast cancer is a leading cause of morbidity and mortality for women worldwide ¹. There has been an increase in personalized breast cancer risk-stratification to identify women who may benefit from earlier and enhanced screening and risk-reduction efforts. While individuals with a pathogenic germline variant (i.e. BRCA1 or BRCA2) are at the highest risk of developing breast cancer ², there are many women without germline variants who are also at elevated risk. High-risk women can also be identified by using validated risk calculators, such as the Gail and IBIS models, which account for personal and family history and the presence of high-risk breast lesions. Much of the work investigating the experiences of high-risk individuals centers on those with a pathogenic germline variant ^3–6, but there is a growing recognition of the need to investigate the experience of others who are also at an elevated risk."